Company Overview
About Cooper Companies (The)
The Cooper Companies, Inc. is a San Ramon, California-based medical device company — publicly traded on the NASDAQ (NASDAQ: COO) as an S&P 500 Health Care component — operating two segments: CooperVision (soft contact lenses for vision correction globally — the second-largest contact lens manufacturer worldwide) and CooperSurgical (fertility and women's health medical devices including IVF laboratory consumables, assisted reproductive technology products, and gynecological surgical instruments) through approximately 15,000 employees in 130 countries. In fiscal year 2024 (ending October 2024), Cooper Companies reported revenues of $3.87 billion (+9% organic growth), with CooperVision generating $2.56 billion from daily, biweekly, and monthly contact lens sales across sphere, toric (astigmatism-correcting), and multifocal (presbyopia-correcting) lens categories, and CooperSurgical generating $1.31 billion from fertility clinic consumables and women's health surgical products. CEO Albert White has executed CooperVision's strategy of capturing the premium daily silicone hydrogel lens market: silicone hydrogel material (higher oxygen permeability improving eye health versus conventional hydrogel) commands a 20-30% price premium over conventional daily lenses, and Cooper's MyDay (premium daily silicone hydrogel) and clariti (value silicone hydrogel) brands compete across price tiers against Johnson & Johnson Vision's Acuvue Oasys and CIBA Vision's AIR OPTIX brands for the global market shift toward dailies — the fastest-growing contact lens modality as patients prefer the convenience and hygiene of discarding lenses after each day's wear.
Business Model & Competitive Advantage
Cooper Companies' contact lens and fertility technology model creates competitive advantages through the specialized manufacturing technology for precision medical optics and the fertility clinic infrastructure relationships: manufacturing soft contact lenses at CooperVision's scale (2+ billion lenses per year) requires precision polymer molding and quality control to tolerances of ±0.25 diopter across billions of individual lens units — a manufacturing capability that took decades to develop at scale and creates significant entry barriers for new competitors. The myopia management lens category (MiSight — FDA-approved daily contact lens clinically proven to slow myopia progression in children) represents CooperVision's highest-growth and highest-margin product line, positioning CooperVision as the category creator in a pediatric contact lens market addressing the global myopia epidemic (increasing rates of childhood nearsightedness in Asia and Western populations). CooperSurgical's fertility business (cryopreservation media, embryo culture systems, genetic testing consumables for IVF laboratories) benefits from the structural growth of assisted reproduction as IVF procedure volumes grow 5-7% annually as fertility rates decline and IVF success rates improve.
Competitive Landscape 2025–2026
In 2025, Cooper Companies competes in soft contact lenses against Johnson & Johnson Vision (NYSE: JNJ, Acuvue brand — contact lens market leader), Alcon (NYSE: ALC, DAILIES Total1 and AIR OPTIX lenses), and Bausch + Lomb (NYSE: BLCO, Ultra lenses) for daily disposable lens market share, myopia management lens adoption in pediatric optometry, and toric/multifocal premium lens positioning with eye care professionals. The myopia management market — MiSight's competition against Ortho-K rigid gas permeable lenses (worn overnight to temporarily reshape the cornea), atropine eye drop protocols, and Essilor Stellest spectacle lenses designed to slow myopia progression — represents a multi-treatment modality competitive landscape where evidence and practitioner training differentiate product adoption. CooperSurgical's ParaGard IUD (copper intrauterine device — non-hormonal contraception) and SAGE ART Compass electronic medical record for IVF clinics provide anchor products in the women's health and fertility adjacent markets. The 2025 strategy focuses on MiSight myopia management global expansion (particularly Asia Pacific where myopia prevalence and awareness are highest), daily silicone hydrogel lens volume growth, and CooperSurgical fertility consumables growth as IVF procedure volume expands globally.
The Cooper Companies (The) Story
Founders
Company Timeline
Major milestones in Cooper Companies (The)'s journey
Leadership Team
Meet the leaders behind Cooper Companies (The)
Albert G. White III
Al White has served as President and CEO of The Cooper Companies since 2018, leading the company through significant growth and strategic expansion. He previously served as Chief Financial Officer from 2016 to 2018, bringing deep financial expertise to his leadership role. Under his leadership, Cooper achieved record fiscal 2024 results with consolidated revenues of $3.90 billion including record performance across both CooperVision and CooperSurgical divisions.
Brian G. Andrews
Brian Andrews has served as Executive Vice President, CFO, and Treasurer since December 2020. He oversees all financial operations, capital allocation, and strategic planning for Cooper's global operations. Andrews brings extensive financial leadership experience and has been instrumental in managing Cooper's acquisition strategy and capital structure.
Daniel G. McBride
Dan McBride has served as Chief Operating Officer since November 2013 and became General Counsel in September 2025, expanding his responsibilities across operations and legal affairs. With over a decade in the COO role, McBride has overseen operational excellence, supply chain management, and manufacturing across Cooper's global footprint, ensuring the company delivers quality products to customers in 130+ countries.
Agostino Ricupati
Agostino Ricupati leads CooperVision as President, overseeing the world's third-largest contact lens manufacturer with flagship brands including MyDay, clariti, Biofinity, and Proclear. He is responsible for driving innovation in contact lens technology, expanding market share, and leading CooperVision's global commercial operations serving eye care professionals and patients in over 100 countries.
Holly Sheffield
Holly Sheffield serves as President of CooperSurgical, leading the company's women's health, fertility, and diagnostics business. She oversees the division's comprehensive portfolio of medical devices and fertility services following major strategic acquisitions including Generate Life Sciences and select Cook Medical assets. Sheffield is responsible for expanding CooperSurgical's market leadership in reproductive health and women's healthcare.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Cooper Companies (The) is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $3870M in revenue, Cooper Companies (The) operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Cooper Companies (The) with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cooper Companies (The)? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cooper Companies (The) Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cooper Companies (The) vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →